Measurable residual FLT3 tyrosine kinase domain mutations before allogeneic transplant for acute myeloid leukemia is a research paper published in Bone Marrow Transplantation (2024). On theSindex it has a DataRank of 0.306. It has been cited 6 times, with 2 citing works in its 1-hop citation network.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.292
From this paper's citation signal
Citation Network Contribution
0.0140
From 1 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 2 citers.
U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute
Grant: 1ZIAHL006163
NIEHS NIH HHS
Grant: 27305C0011
NCI NIH HHS
Grant: U24 CA076518
NIEHS NIH HHS
Grant: 27398C0011
NIEHS NIH HHS
Grant: 27307C0011
Intramural NIH HHS
Grant: ZIA HL006163
National Institutes of Health
Grant: 2U24CA076518-16
A Data Resource for Analyzing Blood and Marrow Transplants
National Institutes of Health
Grant: 1ZIAHL006163-06
Detection, prevention and treatment of acute myeloid leukemia (AML) relapse.
FNIH Biomarkers Consortium project MRD in AML
FWCI
1.77
Citation Percentile
0.9%
Citation Trend
Fields of Study
Keywords